ClinicalTrials.gg
Not yet recruitingNCT07798310PROMPT-SCI IIIUpdated Sep 2, 2026

Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury III (PROMPT-SCI III) Trial

An interventional study of Cycling in Spinal Cord Injuries, Incomplete, sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
107
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This longitudinal cohort study will investigate the clinical benefits of early acute exercise therapy after mild spinal cord injury (SCI). The hypothesis is that early acute exercise therapy after mild SCI will improve neurofunctional recovery (walking, functional independence, motor and sensory recovery) and quality of life one year after the SCI, while decreasing complications during acute care and reducing the care burden (shorter hospital stay and home discharge more likely). For this study, 107 participants with mild SCI will be recruited. Participants will perform daily 30-minute sessions of seated cycling throughout acute care, starting within 2 days of their surgery to decompress the spinal cord. Neurofunctional recovery, quality of life, acute complications and care burden for the participants performing early acute cycling will be compared to a control cohort of patients with mild SCI who did not receive exercise therapy during acute care.

Read the detailed description

GOALS: This longitudinal cohort study will investigate the clinical benefits of early acute exercise therapy after mild spinal cord injury (SCI).

Primary hypothesis: Recovering independent walking 1 year after a mild SCI is more likely with early acute exercise therapy, in comparison with a historical cohort not exposed to early acute exercise therapy. An increase in the percentage of individuals recovering independent walking in the community from 35% to 55% will be considered as a clinically meaningful increase.

Secondary hypothesis: Acute complications, neurological recovery, functional independence, quality of life and care pathway are improved with early acute exercise therapy.

METHODS: For this 5-year study, 107 participants with mild acute traumatic SCI will be recruited. Participants will perform daily 30-minute sessions of seated cycling throughout acute care, starting within 2 days of their surgery to decompress the spinal cord. The immediate response to cycling will be monitored from physiological (hemodynamic and respiratory) and electrophysiological (electromyography and H-reflex testing in lower extremities) assessments. Independent walking in the community (primary outcome) is defined by the ability to walk 100 meters outdoors without technical aids or only with leg orthosis. Secondary outcomes include all complications occurring during acute care (particularly early spasticity, pneumonia, urinary tract infection and pressure injury) and the care pathway (discharge destination and length of stay), as well as neurological recovery, functional independence and quality of life 1 year after the SCI. Outcomes will be compared to a control cohort of patients with mild SCI who did not receive exercise therapy during acute care, and the association with electrophysiological measures will be assessed.

02

Conditions studied

  • Spinal Cord Injuries, Incomplete

Keywords

  • spinal cord injury
  • activity-based therapy
  • exercise therapy
  • rehabilitation
  • acute care
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's planned enrollment of 107 is above the median of 24 across 1,633 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal is the lead sponsor of 34 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adults 18 years or older with non-penetrating traumatic SCI
  • SCI severity AIS grade D (motor function preserved with most key muscles able to move against gravity)
  • NLI between C0 and L2; and spine surgery performed within 48 hours of SCI

Exclusion criteria

Exclusion Criteria:

  • intubated and mechanically ventilated
  • conditions interfering with patient safety or ability to undergo cycling
  • 40 kg/m2 or less (to prevent "frog leg" position during cycling)
  • moderate or severe traumatic brain injury
  • hemodynamic instability
  • pelvic or lower extremity
  • injury with weight-bearing or mobilization restrictions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
107 participants (estimated)

Study arms

  • Experimental
    Activity-based therapy

    Participants will receive daily 30-minute continuous sessions of leg cycling in seated position throughout acute care, starting after surgery as soon as the patient is fit for cycling. While the participant is seated in the armchair in the hospital room, a motorized under desk exerciser will be placed on the floor so that the feet are positioned comfortably on the pedals. The exerciser will be positioned to ensure that maximal knee flexion during cycling will be 70 degrees. Pedal straps are installed to secure the feet while pedaling. Running shoes are provided to participants to prevent harmful pressure and/or friction on heels, and the risk of developing pressure injuries. Participants will pedal at a target cadence of 40 revolutions per minute (RPM).Unless participants actively reach the target cadence of 40 RPM, motor assistance will be noted and titrated/adjusted by the research assistant until the target is reached.

    Device: Cycling

Interventions

  • DeviceCycling

    Seated cycling using motorized under desk exerciser

06

What researchers measure

Primary outcomes

  1. Score from Item 14 of the Spinal Cord Independence Measure ranging from a minimum of 0 to a maximum of 8 (a higher score means a better outcome)

    Ambulation in the community

    Time frame: 1 year

Secondary outcomes

  1. Complications

    Acute complications including pneumonia, urinary tract infection, pressure injury, spasticity, etc.

    Time frame: perioperatively/periprocedurally

  2. Presence or absence of an improvement by one American Spinal Injury Association Impairment Scale grade from baseline to 1 year

    Difference in American Spinal Injury Association Impairment Scale grade between baseline and 1 year

    Time frame: 1 year

  3. Total score of Spinal Cord Independence Measure ranging from a minimum of 0 to a maximum of 100 (a higher score means a better outcome)

    Functional independence

    Time frame: 1 year

  4. Frequence of spasms from Penn Spasm Frequency Scale ranging from a minimum of 0 to a maximum of 4 (a higher score means a worse outcome)

    Severity of spasticity

    Time frame: 1 year

  5. Presence or absence of neuropathic pain

    International Spinal Cord Injury Pain Basic Data Set

    Time frame: 1 year

  6. Physical component score from Short-form 36 ranging from a minimum of 0 to a maximum of 100 (a higher score means a better outcome)

    Physical component of Health-related quality of life

    Time frame: 1 year

  7. Mental component score from Short-form 36 ranging from a minimum of 0 to a maximum of 100 (a higher score means a better outcome)

    Mental component of Health-related quality of life

    Time frame: 1 year

  8. Presence or absence of improvement in motor score by 5 points from baseline to 1 year

    Difference in motor score from baseline to 1 year

    Time frame: 1 year

  9. Presence or absence of improvement in sensory scores by 10 points from baseline to 1 year

    Difference in sensory scores between baseline and 1 year

    Time frame: 1 year

  10. Presence or absence of improvement by 2 neurological levels of injury from baseline to 1 year

    Difference in neurological level of injury between baseline and 1 year

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — The IPD collected for the study are not publicly available. However, IPD will be made available to others upon reasonable request, and with permission from our Ethics committee.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07798310
Lead sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Responsible party
Jean-Marc Mac-Thiong (Professor, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal) — Principal investigator
First posted
Sep 1, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Jan 31, 2031 (estimated)
Completion
Jan 31, 2031 (estimated)
Last update
Sep 2, 2026

Study contacts

Jean-Marc Mac-Thiong, MD, PhD
Contact
jean-marc.mac-thiong@umontreal.ca
1+514-338-2222
Andreane Richard-Denis Richard-Denis, MD, MSc
Contact
andreane.rdenis@umontreal.ca
1+514-338-2222
Jean-Marc Mac-Thiong, MD, PhD
principal investigator · Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion